Showing posts with label botox. Show all posts
Showing posts with label botox. Show all posts

Friday, June 22, 2007

Botox Treatment for the Bladder

Botox Inhibits Bladder From Contracting
By Denise Dador

June 21, 2007 (KABC-TV) - Frequency means having to go to the bathroom at least every hour. Urgency means you just can't wait. You've got to go right now. If these symptoms sound familiar, you might want to consider enrolling in a clinical trial for a drug many people are familiar with.

Erika Lopez's job as an associate producer for Mix Magazine keeps her on the go. But every 20 minutes, she'd have to stop what she's doing.

Lopez: "It was a big inconvenience everywhere I went. I had to revolve my life around where I could find a bathroom."

Multiple sclerosis caused Erika to have incontinence and an overactive bladder.

Lopez: "I've been on medication, I've done cathetering, I've done everything you might imagine."

A few months ago, she decided to enroll in an unusual clinical trial that involves injecting Botox in her bladder. Botox is widely known as a facial wrinkle remover.

David Ginsberg, USC Keck School of Medicine: "So instead of injecting Botox, let's say into the brows and taking your wrinkles out, you can inject a small amount of the Botox into the bladder, throughout the bladder."

The needle is inserted through the urethra using a cystoscope. The effect lasts about six to nine months.

The procedure is done right in the doctor's office. It takes about five minutes. Patients will receive anywhere from 100-200 units of Botox and it usually takes about 10 to 20 injections.

The Botox inhibits Lopez's bladder from contracting.

And while Dr. Ginsberg says most patients tolerate the procedure well, Erika says she felt a lot of discomfort.

Lopez: "The level of discomfort is somewhat like childbirth ... The results have been equally as rewarding."

Erika's symptoms of frequency and urgency have completely disappeared. But in her case the Botox has worked a little too well.

Dr. Ginsberg: "I think probably the biggest two risks are that are that it doesn't work, or it works so well you can't go. That would be temporary."

It happens in about 10 percent of patients. Despite this side effect, Erika says the Botox injections have greatly improved her quality of life.

Lopez: "I do injections for MS and then I do that, and I'm a healthy, happy, lively woman."

To find out if you're eligible for the trial or to get more information, call Charlotte Lee at (323) 865-3774, or visit https://www.praxisdirectstudies.com/Dignity/Default.aspx?PageName=FindPhysician.

Copyright © 2007 KABC-TV. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Wednesday, February 28, 2007

Botox 'major advance' in bringing bladder relief





28.02.2007

It has won an army of celebrity fans for banishing crow's feet and frown lines, but the use of Botox to combat bladder problems such as incontinence has been hailed as a 'major advance' by a urology expert.

Christopher Chapple, a visiting professor at Sheffield Hallam University, said poisonous botulinum toxin could be used therapeutically to treat bladder storage and sensation problems such as incontinence and cystitis. Professor Chapple, who is carrying out new research into the treatment at the University's Biomedical Research Centre, said it had successfully helped eighty per cent of cases during recent trials.

He explained in a lecture at Sheffield Hallam that a simple injection of the substance into the bladder lining could bring relief to some of the ten per cent of people in the UK who currently suffer from an overactive bladder, which is resistant to other drug therapy.

He said: "Doctors are now realising the role of the bladder lining as the cause of problems to do with frequent or painful passing of urine. By injecting the patient's bladder lining with botulinum toxin, we can block the release of nerve transmitter substances and sensory nerves, which means that the patient doesn't feel the need to go to the toilet as often. It also means we don't have to rely on intensive drug therapy, or invasive surgery.

"Around ten per cent of the current UK population has an overactive bladder, while nearly a third of us will experience bladder storage or sensation problems at some point in our lives.

"The bladder normally stores urine at a low pressure, until it can be passed at a socially acceptable time, but some people have problems storing urine and need to go frequently, and urgently. Problems can occur with age, or sometimes as the result of a neurological disorder such as multiple sclerosis.

"Imagine you've come home after a few drinks, you need to pee, and you're fumbling to get the key in the door - that's the sensation some of these people experience every day."

He added: "Treatment with botulinum toxin has been successful in eighty per cent of cases so far. Work is still ongoing, but there is no doubt that it is a major advance that will really improve sufferers' quality of life."

Botulinum toxin, commercially known as Botox, is highly toxic, but is used in minute doses to control muscle spasms. Demi Moore and Madonna have reportedly benefited from its cosmetic, wrinkle-softening effects.

The simple bladder lining treatment lasts between three and six months, and can be administered to outpatients under local anesthetic.

Around fifty people have currently been treated with the botulinum toxin treatment. Professor Chapple and his team are now involved in clinical trials, and will publish further findings at the end of the current, 18-month long research project.

Professor Chapple has a specialist interest in reconstructive surgery and is also working on engineering tissue to carry out urethral reconstruction. Other research is ongoing in the research group to investigate the underlying problems behind bladder and prostate problems.

Christopher Chapple is a Consultant Urological Surgeon at the Royal Hallamshire Hospital, part of Sheffield Teaching Hospitals NHS Trust.

He spoke at Sheffield Hallam University on Wednesday 21 February, 2007.
Kate Burlaga | Quelle: alphagalileo
Weitere Informationen: www.shu.ac.uk/news